CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer

CD276 can discriminate between tumor derived and normal CECs (circulating endothelial cells). We evaluated whether CD276(+)CEC is a clinically relevant biomarker to predict response to palliative systemic therapy in patients with metastatic colorectal cancer (mCRC). Samples were prospectively collec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gootjes, Elske C., Kraan, Jaco, Buffart, Tineke E., Bakkerus, Lotte, Zonderhuis, Barbara M., Verhoef, Cornelis, Verheul, Henk M.W., Sleijfer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016770/
https://www.ncbi.nlm.nih.gov/pubmed/31948091
http://dx.doi.org/10.3390/cells9010124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016770/
https://www.ncbi.nlm.nih.gov/pubmed/31948091
http://dx.doi.org/10.3390/cells9010124

Ejemplares similares